$9.47
0.060.64%
At close: Aug 14, 5:00 PM EST
$9.47
N/A
After Hours: Aug 14, 4:26 PM EST
ADMA Biologics Inc Earnings Estimates
ADMANASDAQ
ADMA Biologics Earnings Estimates, EPS & Revenue | NASDAQ:ADMA
ADMA Biologics (ADMA) is scheduled to report Q3 earnings on November 4, 2026. Analysts estimate EPS of $0.2 and quarterly revenue of $138.46M.
In the most recent quarter (Q2), ADMA Biologics reported EPS of $0.16, missing estimates of $0.17 by 0.06%. Revenue came in at $124.39M, missing the estimate of $126.08M by 0.01%.
ADMA Biologics has missed EPS estimates in 2 consecutive quarters.
Over the last 4 quarters, ADMA Biologics has averaged an EPS surprise of 0.07% and a revenue surprise of 0.06%.
Earnings Date
Nov 4
EPS Estimate
$0.200
Quarterly Revenue Estimate
$138.46M
Annual Revenue
$512.27M
as of Jun 30
ADMA Biologics Earnings History
Analyze the earnings history of ADMA Biologics using advanced sorting and filters.
ADMA Biologics (ADMA) Earnings Per Share
The chart below shows ADMA Biologics's reported EPS compared to analyst estimates over recent quarters.
ADMA Biologics (ADMA) Revenue
The chart below shows ADMA Biologics's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is ADMA Biologics (NASDAQ:ADMA) reporting earnings?
ADMA Biologics (ADMA) is scheduled to report earnings on November 4, 2026. The last reported earnings were for reported on August 5, 2026 for Q2.
What were the latest earnings per share (EPS) for ADMA Biologics (NASDAQ:ADMA)?
The Actual EPS was $0.16, which missed the estimate of $0.17.
What were ADMA Biologics’s (NASDAQ:ADMA) revenues?
The Actual Revenue was $124.39M, which missed the estimate of $126.08M.
